WuXi AppTec (02359) Removed from the 1260H List of Chinese Military Companies
WuXi AppTec (02359) announced that on November 9, 2026, the Company was informed of the Department of Defense's decision to remove WuXi AppTec from the CMC List under Section 1260H. The Deputy Secretary of Defense determined that the Department should comply with the court's order granting the Company's motion for a preliminary injunction and remove WuXi AppTec from the Department of Defense's updated 1260H List.
WuXi AppTec (02359) announced that on November 9, 2026, the Company was informed of the Department of Defense's decision to remove WuXi AppTec from the CMC List under Section 1260H. The Deputy Secretary of Defense determined that the court's order granting the Company's motion for a preliminary injunction should be complied with by removing WuXi AppTec from the Department of Defense's updated 1260H List.
This decision relieves the Company from further adverse effects arising from the designation. The Company will continue to remain committed to serving its customers and empowering them to develop life-saving and life-improving medicines for patients.
Related Articles
LEE'S PHARM (00950) repurchased 2,000 shares on November 9 for HK$2,140.
RIBOLIFE-B (06938) submits an Investigational New Drug (IND) application for a Phase I clinical trial of the dual-target drug SR122 injection for the treatment of mixed dyslipidemia and severe hypertriglyceridemia.
Marvell Technology, Inc. (MRVL.US)'s US$115 billion "marriage of the century" has lost favor! The stock has fallen more than 40%, and experts estimate only a 50% probability of completion.
LEE'S PHARM (00950) repurchased 2,000 shares on November 9 for HK$2,140.
RIBOLIFE-B (06938) submits an Investigational New Drug (IND) application for a Phase I clinical trial of the dual-target drug SR122 injection for the treatment of mixed dyslipidemia and severe hypertriglyceridemia.
Marvell Technology, Inc. (MRVL.US)'s US$115 billion "marriage of the century" has lost favor! The stock has fallen more than 40%, and experts estimate only a 50% probability of completion.
